Rapamycin also inhibits thymidylate synthase expression and, when combined with pemetrexed (a widely used drug for NSCLC treatment), both drugs inhibit NSCLC cancer cell growth in both in vitro and in vivo models [133]. This evidence concerns the gene TYMS and non-small cell lung carcinoma.